Recombinant Influenza vaccine candidate clinical trials

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

This study is testing a new plant-based flu vaccine that uses different parts of the flu virus to see if it's safe and works well. It's for adults 18 and older, and we want to find the best dose.